Trial
NCT04953312
Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Gustave Roussy, Cancer Campus, Grand Paris; URC-CIC Paris Descartes Necker Cochin
Condition
Severe/Moderate Coronavirus
Intervention
Blood samples
Why stopped
Abandonment of the study project
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-12